HRT Financial
LTRN icon

HRT Financial’s Lantern Pharma LTRN Stock Holding History

HRT Financial’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30K Buy
+30,307
New +$73K ﹤0.01% 4431

Other funds holding LTRN

CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
NewEdge Advisors
NewEdge Advisors New Orleans, Louisiana $34.5B AUM 23.55% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

HRT Financial's LTRN Position: Q3 2026 in Review

HRT Financial opened a new position in Lantern Pharma (LTRN) in Q3 2026: 30,307 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #4431 among its holdings.

36 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

  • HRT Financial held 30,307 shares of Lantern Pharma worth $30K as of Q3 2026.
  • Lantern Pharma was a new HRT Financial position in Q3 2026.
  • Lantern Pharma made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4431 holding.
  • 36 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.